As of 2024-10-08, the Relative Valuation of Infinity Pharmaceuticals Inc (INFI) is (37.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 USD, the upside of Infinity Pharmaceuticals Inc based on Relative Valuation is -84411.0%.
The range of the Relative Valuation is (32.02) - (27.10) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.4x - 54.5x | 40.0x |
| Forward P/E multiples | 18.2x - 21.5x | 19.8x |
| Fair Price | (32.02) - (27.10) | (37.69) |
| Upside | -71722.0% - -60724.9% | -84411.0% |
| Date | P/E |